MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Update on Chronic Low Back Pain Program, page-197

  1. 5,838 Posts.
    lightbulb Created with Sketch. 2110
    First of all, we are all speculating about whether Surgcentre would be involved in trials. We have no idea. Second, most drug trials are run by the companies who own the product. Or someone they hire to run the trial. Either way, there is a financial incentive to consider and need to find a way to control for that. Generally, the fact that the doctors and centers have no idea whether they are giving a placebo should play a large part in minimizing the problem. Also, there would be auditing of trial procedures.

    See this article that discusses some of the ways they can try to prevent conflicts from influencing trial outcomes:

    https://www.centerwatch.com/articles/13288

    Conflicts of interest and the clinical investigator


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.